Bioretec Oy ("Bioretec" or the "Company"), a pioneer in biodegradable orthopedic implants, has been granted Breakthrough Device Designation ...
21h
Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
Sobi® (STO: SOBI) has entered into a definitive agreement to acquire Arthrosi Therapeutics, Inc. (Arthrosi), a private late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback